Filter
706
Filtered Results: 706
Text search:
pharmaceutical
quality
control
laboratories
Featured
Recommendations
78
New Publications
217
Language
Document type
No document type
360
Studies & Reports
131
Guidelines
114
Strategic & Response Plan
48
Manuals
36
Training Material
7
Situation Updates
6
Fact sheets
3
Resource Platforms
1
Countries / Regions
India
43
Kenya
33
Ethiopia
29
Nigeria
18
Western and Central Europe
17
South Africa
17
Sierra Leone
15
Uganda
15
Ghana
14
Nepal
13
Global
13
Bangladesh
13
Liberia
13
Malawi
12
Philippines
11
Tanzania
11
Africa
10
Eastern Europe
10
Rwanda
9
Cambodia
9
Zambia
9
Ukraine
7
Senegal
6
Burkina Faso
6
Zimbabwe
6
South–East Asia Region
6
Namibia
6
Myanmar / Burma
6
Syria
5
Latin America and the Carribbean
5
Eswatini/ Swaziland
5
Thailand
4
Lesotho
4
Benin
4
Haiti
4
Botswana
4
Indonesia
4
Cameroon
3
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Pakistan
3
Albania
2
Laos
2
Guinea
2
USA
2
Asia
2
Venezuela
2
Western Pacific Region
2
Vietnam
2
Madagascar
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Peru
1
Mozambique
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
Gabon
1
Turkmenistan
1
France
1
Maldives
1
Papua New Guinea
1
Moldova
1
Sudan
1
Yemen
1
Mali
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
335
Clinical Guidelines
39
Key Resources
35
Public Health
21
Pharmacy & Technologies
21
Women & Child Health
13
Capacity Building
3
Toolboxes
AMR
122
Pharmacy
55
COVID-19
54
TB
47
Rapid Response
36
NTDs
22
HIV
18
Mental Health
16
Planetary Health
11
Conflict
10
Health Financing Toolbox
9
Caregiver
8
Polio
8
Ebola & Marburg
6
Global Health Education
6
Specific Hazards
5
Natural Hazards
4
NCDs
4
Refugee
3
Cholera
3
Zika
2
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
"The aim of this book remains as for the first edition, namely to provide an initial point of ready
reference for the identification of hazards and precautions for dangerous chemicals. It is targeted
not only at those in the chemical and process industries, but also anyone likely to work with
che...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Measuring progress towards universal health coverage.
This sixth edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, health care expenditure and financing and quality of care across 27 Asia-...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Climate change is damaging human health now and is projected to have a greater impact in the future. Low- and middle-income countries are seeing the worst effects as they are most vulnerable to climate shifts and least able to adapt given weak health systems and poor infrastructure. Low-carbon appro...
As a lower-middle-income country (LMIC), South Africa (SA) bears
the burden of maternal and neonatal mortality similar to other sub-
Saharan African countries. According to the Saving Mothers Report
2017/19, there has been a progressive and sustained reduction
in institutional maternal mortality...
Thefirst report on Latin America and the Carribean presents key indicators on health and health systems in 33 Latin America and the Caribbean countries. . Analysis is based on the latest comparable data across almost 100 indicators including equity, health status, determinants of health, health car...
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analysis, and Phase IV studies. Before new interventions...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
